1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Skin infections

Bimekizumab for treating moderate to severe hidradenitis suppurativa [ID6134]

In development [GID-TA11045] Expected publication date: TBC

  • Project information
  • Project documents

  • Draft consultation document (downloadable version) PDF 296 KB 07 October 2024  
  • Committee papers PDF 8.46 MB 07 October 2024  
  • Presentation Slides redacted PowerPoint 627 KB 07 October 2024  
  • Equality impact assessment (downloadable version) PDF 129 KB 07 October 2024  
  • Draft consultation document (online commenting)